de Carvalho Barros Lucimário, Avancini Clarissa, Gurgel Ricardo Queiroz, de Amorim Robson Luís Oliveira, Kolias Angelos G, Paiva Wellingson Silva, Oliveira Arthur Maynart Pereira
Department of Medicine, Federal University of Sergipe, Aracaju, Brazil.
Graduate Program in Health Sciences, Federal University of Sergipe, Aracaju, Brazil.
Neurosurg Rev. 2025 May 23;48(1):437. doi: 10.1007/s10143-025-03596-w.
Chronic subdural hematomas (cSDH) are increasingly prevalent, particularly among the elderly, and often require surgical intervention as the standard treatment. The placement of drains following surgical evacuation of cSDH is widely recognized as an effective strategy to reduce recurrence rates and improve clinical outcomes. However, the optimal location for drain placement remains a topic of debate. This study aims to comparatively evaluate the efficacy and safety of subgaleal/subperiosteal drainage (SGPD) and subdural drainage (SDD) techniques in patients with cSDH. This study followed PRISMA guidelines and the Cochrane Handbook. Systematic searches were conducted in PubMed, Embase, Scopus, and Web of Science. Comparative studies of SGPD and SDD in patients undergoing surgical treatment for cSDH were included. The primary outcome was the recurrence rate. Secondary outcomes included favorable clinical outcomes (mRS 0-3), mortality, and complications such as infections, intracerebral hemorrhages, pneumocephalus, and seizures. The risk of bias was assessed using the Cochrane RoB 2 and ROBINS-I tools, and statistical analyses employed fixed or random-effects models based on heterogeneity, utilizing RStudio software. A total of 21 studies involving 6,430 patients were included. SGPD was associated with a significant reduction in recurrence rates compared to SDD (RR = 0.87; 95% CI [0.76; 0.99]; p = 0.0317; I = 2,9%). No significant differences were observed in secondary outcomes, including mortality (RR = 0.86; 95% CI [0.72; 1.03]; p = 0.0995; I = 0.0%), favorable clinical outcomes (RR = 1.00; 95% CI [0.97; 1.03]; p = 0.9495; I = 0.0%), infectious complications (RR = 0.88; 95% CI [0.57; 1.34]; p = 0.5470; I = 0.0%), seizures (RR = 0.81; 95% CI [0.51; 1.28]; p = 0.1774; I = 26.2%), pneumocephalus (RR = 0.94; 95% CI [0.71; 1.25]; p = 0.6819; I = 1.7%), and intracerebral hemorrhage (RR = 0.60; 95% CI [0.32; 1.10]; p = 0.0982; I = 0.0%). The present meta-analysis suggests that SGPD is more effective in reducing the recurrence rate compared to SDD in the surgical treatment of cSDH. However, no statistically significant differences were observed in the other evaluated outcomes. Future studies, particularly multicenter clinical trials, are needed to confirm these findings. Clinical trial number Not applicable.
慢性硬膜下血肿(cSDH)越来越普遍,尤其是在老年人中,并且通常需要手术干预作为标准治疗方法。在cSDH手术清除后放置引流管被广泛认为是降低复发率和改善临床结局的有效策略。然而,引流管放置的最佳位置仍然是一个有争议的话题。本研究旨在比较评估帽状腱膜下/骨膜下引流(SGPD)和硬膜下引流(SDD)技术在cSDH患者中的疗效和安全性。本研究遵循PRISMA指南和Cochrane手册。在PubMed、Embase、Scopus和Web of Science中进行了系统检索。纳入了对接受cSDH手术治疗的患者进行SGPD和SDD的比较研究。主要结局是复发率。次要结局包括良好的临床结局(改良Rankin量表评分0 - 3分)、死亡率以及感染、脑出血、气颅和癫痫等并发症。使用Cochrane RoB 2和ROBINS - I工具评估偏倚风险,并根据异质性采用固定或随机效应模型进行统计分析,使用RStudio软件。总共纳入了21项涉及6430例患者的研究。与SDD相比,SGPD与复发率的显著降低相关(风险比[RR]=0.87;95%置信区间[CI][0.76;0.99];p = 0.0317;I² = 29%)。在次要结局方面未观察到显著差异,包括死亡率(RR = 0.86;95% CI[0.72;1.03];p = 0.0995;I² = 0.0%)、良好的临床结局(RR = 1.00;95% CI[0.97;1.03];p = 0.9495;I² = 0.0%)、感染性并发症(RR = 0.88;95% CI[0.57;1.34];p = 0.5470;I² = 0.0%)、癫痫(RR = 0.81;95% CI[0.51;1.28];p = 0.1774;I² = 26.2%)、气颅(RR = 0.94;95% CI[0.71;1.25];p = 0.6819;I² = 1.7%)和脑出血(RR = 0.60;95% CI[0.32;1.10];p = 0.0982;I² = 0.0%)。本荟萃分析表明,在cSDH的手术治疗中,与SDD相比,SGPD在降低复发率方面更有效。然而,在其他评估结局中未观察到统计学上的显著差异。需要进一步的研究,尤其是多中心临床试验,以证实这些发现。临床试验编号:不适用。